The short version of triagonist fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
Pharmacologically, retatrutide acts as a triple agonist at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. Activation of the first two receptors is associated with improved insulin secretion and reduced appetite. The glucagon receptor component is thought to increase energy expenditure, a mechanism that distinguishes this molecule from dual-agonist compounds. Researchers continue to investigate how the three activities interact and whether the combined profile offers advantages that justify additional clinical testing.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
冻干粉通常在低温环境下保存，复溶之后需要按指定条件在较短时间内使用。反复冻融和剧烈振荡可能促进聚集，低吸附容器则能减少多肽在管壁上的损失。批号、日期与处理条件的完整记录，是后续复核与问题追溯的基础。
供应环节涉及来源核实与文件审核两类工作。分析证书、批次记录以及第三方检测报告构成常见的可追溯材料。来源不清的样品很难确认身份与纯度，因此核实步骤在实际操作中具有明确意义。缺少方法细节的报告通常无法复核。
多肽类化合物的表征通常依赖色谱与质谱联用技术。反相高效液相色谱用于评估纯度与有关物质，质谱用于确认分子量，肽图分析通过酶解碎片比对验证一级结构。这些手段组合使用，可以把目标产物与降解产物或类似物区分开来。单一方法往往不足以完成完整确认。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Contains non-natural residues |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist profile |
| Route of administration | Subcutaneous injection | In clinical trial settings |
| Development status | Investigational | Not approved in major markets |
| Approximate molecular mass | About 4.7 kDa | Peptide-scale molecule |
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Retatrutide is an investigational peptide studied for obesity and type 2 diabetes. It is a single synthetic molecule designed to activate three metabolic receptors simultaneously. The compound belongs to the incretin mimetic family, a group of peptides that imitate gut hormones involved in appetite and glucose control. Its research code is LY3437943, and it remains under clinical study rather than cleared for routine medical use.
Acting as a triple agonist, the molecule binds the GLP-1, GIP, and glucagon receptors. GLP-1 activity slows gastric emptying and dampens appetite, while GIP signaling contributes to insulin sensitivity and fat metabolism. Glucagon receptor engagement raises energy expenditure and encourages fat breakdown, although it can also elevate blood glucose. Combining three pathways is intended to yield larger weight reduction than single or dual agonists, and researchers continue to examine how the balance among them shapes tolerability.
On 18 January, ambassadors from all 27 member states of the EU held an emergency meeting on Trump's threats. After Trump reversed his decision on implementing tariffs, EU officials were sceptical, but announced on 22 January that approval of the trade agreement would resume.
== Occurrence == For an individual chemical or class of chemical compounds to impart a smell or fragrance, it must be sufficiently volatile for transmission via the air to the olfactory system in the upper part of the nose. A 1976 analysis of 2,000 food aroma compounds found a peak in molecular weights around 135–155 and an upper limit near 310, with the most potent compounds all weighing less than 200 Da. A 2003 paper claims the sharp cutoff near 300 Da is instead attributable to the size limitations of olfactory receptors, with higher rates of anosmia for compounds close to this limit such as galaxolide. Fragrance compounds are found in various foods, such as fruits and their peels, wine, spices, floral scent, perfumes, fragrance oils, and essential oils. For example, many form during the ripening of fruits and other crops. Wines have more than 100 aromas that form as byproducts of fermentation. Also, many of the aroma compounds play a significant role in the production of compounds used in the food service industry to flavor, improve, and generally increase the appeal of their products.
=== Microscopy and imaging === An infrared microscope allows samples to be observed and spectra measured from regions as small as 5 microns across. Images can be generated by combining a microscope with linear or 2-D array detectors. The spatial resolution can approach 5 microns with tens of thousands of pixels. The images contain a spectrum for each pixel and can be viewed as maps showing the intensity at any wavelength or combination of wavelengths. This allows the distribution of different chemical species within the sample to be seen. This technique has been applied in various biological applications including the analysis of tissue sections as an alternative to conventional histopathology, examining the homogeneity of pharmaceutical tablets, and for differentiating morphologically-similar pollen grains.
I do almost all of my music work out of my studio at home. Ok, here goes: I use a pair of Adats, a Soundcraft Ghost for mixing, a bunch of outboard Symetrix and Lexicon processors for dynamics and effects, and an Eventide Ultraharmonizer DSP4000 for pre/post processing and vocal effects. For keyboards I use a mix of older and newer stuff. I have an old Prophet 5, a Casio FZ-1, a Roland MKS-50 with a programmer and an Oberheim Matrix 6. For newer gear, the Roland JP-8000, MC303, and the Novation Bass Station are nice for creating new sounds quickly. I also have a little Korg 05/wR with a software programmer that can be coaxed into making some fat sounds (no analog filter tho). I'm pretty religious about not using presets, so I really favor the more programmable synths. A lot of the recording and arrangement happens inside a PC; I run Logic Audio 2.5 for digital recording, post-processing and midi arrangement. I use an Audiomedia III card for digital transfers to and from a Tascam DA-30 dat. For guitar I use my trusty Les Paul through a Marshall half-stack, with an Oberheim Echoplex on the fx loop.
Sources: en.wikipedia.org
Ascherson is the author of several books on the history of Poland and Ukraine; work has appeared in The Guardian ; contributed scripts for the documentary series The World at War (1973–74) and the Cold War (1998). He has also been a regular contributor to the London Review of Books. Gilad Atzmon, Israeli-British Holocaust denier, agent provocateur, author, writer, prolific blogger, saxophonist for the Blockheads and Pink Floyd; bebop jazz musician of Israeli birth and Ashkenazi origin. David Baddiel (born 28 May 1964) comedian, op-ed writer, broadcaster and author of over ten books, including Jews Don't Count, which is about antisemitism, under-representation in popular media, double standards against, exclusion of, and ethnic or racial prejudice against Jews in Britain. Ivor Baddiel, brother of David Baddiel scriptwriter and author. He regularly writes for some of the biggest shows on British television including The BAFTAs (British Academy Film Awards), The X Factor and The National Television Awards. Ivor is also the author of nineteen books for both children and adults. Sir Michael Balcon (19 May 1896 – 17 October 1977) prolific author and film producer known for leadership of Ealing Studios, one of the most important British film studios; known for his leadership, and his guidance of Alfred Hitchcock;co-founded Gainsborough Pictures, later working with Gaumont British and MGM-British; chairman of the British Film Institute; grandfather of Daniel Day-Lewis.
In contrast to ALP, levels of ALT, AST, GGT, and lactate dehydrogenase are only slightly changed or largely unchanged during pregnancy. Bilirubin levels are significantly decreased in pregnancy. In pregnancy conditions such as hyperemesis gravdirum, ALP levels can reach 215 IU/L, meanwhile, in pre-eclampsia, ALP can reach 14 IU/L, and in HELLP syndrome ALP levels can reach 15 IU/L.
Enzymes with this activity include flavanone 7-O-beta-glucosyltransferase, which uses UDP-glucose to transfer the sugar component. Flavanones like naringenin can undergo a rearrangement reaction which converts them first to the unstable hydroxlated isoflavanone, which loses water to give an isoflavone. The enzymes involved are isoflavonoid synthase and 2-hydroxyisoflavanone dehydratase.
=== Neoantigens === Many tumors express mutations. These mutations potentially create new targetable antigens (neoantigens) for use in T-cell immunotherapy. The presence of CD8+ T cells in cancer lesions, as identified using RNA sequencing data, is higher in tumors with a high mutational burden. The level of transcripts associated with the cytolytic activity of natural killer cells and T cells positively correlates with mutational load in many human tumors. In non–small cell lung cancer patients treated with lambrolizumab, mutational load shows a strong correlation with clinical response. In melanoma patients treated with ipilimumab, the long-term benefit is also associated with a higher mutational load, although less significantly. The predicted MHC binding neoantigens in patients with a long-term clinical benefit were enriched for a series of tetrapeptide motifs that were not found in tumors of patients with no or minimal clinical benefit. However, human neoantigens identified in other studies do not show the bias toward tetrapeptide signatures. Finally, effectiveness of neoantigens may also be regulated by the specific HLA repertoire possessed by specific patient sub-groups.
The usage of the term "hegemonising swarm" in this context is considered derisive in the Culture and among other Involved and is used to indicate their low regard for those with these ambitions by comparing their behaviour to that of mindless self-replicating technology. The Culture's central moral dilemma regarding intervention in other societies can be construed as a conflict between the desire to help others and the desire to avoid becoming a hegemonising swarm themselves.
Sources: en.wikipedia.org
== Career == As noted in his obituary in Clinical Chemistry, Masahide "graduated from Yamaguchi Medical School in 1961. During 1965, he served as an internist for the Hiroshima Atomic Bomb Casualty Committee. Several years later, in 1967, he was appointed the Chief of the Clinical Chemistry Department at Kawasaki Hospital. In 1970, he did a fellowship in the United States at the Michael Reese Hospital in Chicago, IL, which gave him exposure to the US medical system. Two years later he became an Assistant Professor of Internal Medicine at Kawasaki Medical School and rose quickly in the academic ranks to become a Full Professor of Laboratory Diagnosis in 1976 and, ultimately, Vice President of Kawasaki Paramedical College." He was appointed Professor and Director of the Department of the Clinical Laboratory at Kochi Medical School, Kochi, Japan in 1981. There, he developed his automation system. Masahide published many papers between 1981 and 1999, the most notable of which was a monograph on laboratory automation sponsored by the A&T Corporation.
== Chemistry == LAAM, or levomethadyl acetate, is the levo isomer of acetylmethadol, or α-methadyl acetate. The dextro isomer, d-alphacetylmethadol (d-α-acetylmethadol), is more potent but shorter acting. The levo isomer is also less toxic with an LD50 in mice of 110 mg/kg s.c. and 172.8 mg/kg orally as opposed to LD50s of 61 mg/kg s.c. and 118.3 mg/kg orally for dl-α-methadyl acetate. It has a melting point of 215 °C and a molecular weight of 353.50. β-methadyl acetate also exists, but is more toxic and less active than α-methadyl acetate and has no current medical use.
There are various competing calculation methods for the drug accumulation ratio, yielding somewhat different results. A commonly used formula defines Rac as the ratio of the area under the curve (AUC) during a single dosing interval under steady state conditions to the AUC during a dosing interval after one single dose:
== How to determine GBeta == The index is derived from a mathematical model of insulin-glucose homeostasis that incorporates fundamental physiological motifs. For diagnostic purposes, it is calculated from fasting insulin and glucose concentrations with:
There are three types of myomeres observed in fish-like chordates: amphioxine (lancelet), cyclostomine (jawless fish), and gnathostomine (jawed fish). All myomeres flex the body laterally into concavity to provide force for locomotion. Since myomeres are composed of multinucleated myofibers (contractile cells), force can be generated via muscle contraction that gets transmitted by the intricate connective tissue (myosepta) network. Myomeres compose most of the lateral musculature and provide propulsive force to travel along the line of travel. In this sense, they cause flexion to either side in order to produce locomotor force (the forward swimming motion). Myomeres attach to centra of vertebrae, and neural and haemal spines. The folded shape of each myomere as V- or W-shaped extends over various axial segments, allowing fibers control over a large amount of the body. There are different variations of myomere activation depending on the type of swimming or movement. For example, high loading situations such as fast-starts and turning require almost maximal myomere activation in teleost fish. Further, if swim speeds are lower and movement is in one plane, there is less activation of myomeres. Research has discovered that fish are able to spatially restrict axial myomeres during different swimming behaviors.
Sources: en.wikipedia.org
It is designed as a triple agonist acting on the GLP-1, GIP, and glucagon receptors. This combination is intended to influence appetite, insulin secretion, and energy expenditure. Single-receptor and dual-receptor compounds act on a narrower set of targets.
No. It remains investigational, and phase 3 results have not been fully published or reviewed by regulators. Official approval status should be confirmed through regulatory agencies rather than secondary sources.
The added glucagon receptor activity is the main difference in its mechanism. Whether that addition produces meaningful benefits in clinical outcomes is still being studied. Comparisons between compounds rest largely on indirect rather than head-to-head trial data.
常用质谱测定分子量，再结合肽图或序列分析验证一级结构。单一检测手段一般难以排除结构相近的类似物。多种方法相互印证更为可靠。